浏览与细胞增殖紊乱、肿瘤学研究及抗增殖筛选相关的疾病导向型小分子。利用本页面围绕生长调控生物学、疾病机制及后续验证工作流程构建化合物集合。
细胞增殖性疾病
按类别选购
肠易激综合征(DOID:9778) irritable bowel syndrome (DOID:9778)
2,379多囊卵巢综合征(DOID:11612) polycystic ovary syndrome (DOID:11612)
2,022慢性疲劳综合征(DOID:8544) chronic fatigue syndrome (DOID:8544)
965努南综合征(DOID:3490) Noonan syndrome (DOID:3490)
81婴儿猝死综合征(DOID:9007) sudden infant death syndrome (DOID:9007)
41贝克威思-威德曼综合征(DOID:5572) Beckwith-Wiedemann syndrome (DOID:5572)
21心面皮肤综合征(DOID:0060233) cardiofaciocutaneous syndrome (DOID:0060233)
6Pitt-Hopkins综合征(DOID:0060488) Pitt-Hopkins syndrome (DOID:0060488)
229奥利尔病(DOID:4624) Ollier disease (DOID:4624)
7歌舞伎综合征(DOID:0060473) Kabuki syndrome (DOID:0060473)
126罗宾诺综合征(DOID:0060254) Robinow syndrome (DOID:0060254)
498CHARGE综合征(DOID:0050834) CHARGE syndrome (DOID:0050834)
44马夫奇综合征(DOID:0060221) Maffucci syndrome (DOID:0060221)
0施瓦赫曼-戴蒙德综合征(DOID:0060479) Shwachman-Diamond syndrome (DOID:0060479)
129高安氏动脉炎 (DOID:2508) Takayasu's arteritis (DOID:2508)
491卓-艾综合征(DOID:0050782) Zollinger-Ellison syndrome (DOID:0050782)
61Klippel-Trenaunay 综合征 (DOID:2926) Klippel-Trenaunay syndrome (DOID:2926)
8莫瓦特-威尔逊综合征(DOID:0060485) Mowat-Wilson syndrome (DOID:0060485)
65巴雷特瑟-温特综合征(DOID:0060229) Baraitser-Winter syndrome (DOID:0060229)
0EAST综合征(DOID:0060484) EAST syndrome (DOID:0060484)
167艾卡迪综合征(DOID:8461) Aicardi syndrome (DOID:8461)
47VACTERL综合征(DOID:14679) VACTERL association (DOID:14679)
11库伦·德弗里斯综合征 (DOID:0050880) Koolen de Vries syndrome (DOID:0050880)
24帕廷顿综合征(DOID:14744) Partington syndrome (DOID:14744)
22下颌面骨发育不全伴脱发(DOID:0060365) mandibulofacial dysostosis with alopecia (DOID:0060365)
81眼耳综合征 (DOID:0060482) oculoauricular syndrome (DOID:0060482)
30戈德堡-施普林岑综合征(DOID:0060481) Goldberg-Shprintzen syndrome (DOID:0060481)
22Lown-Ganong-Levine 综合征 (DOID:13087) Lown-Ganong-Levine syndrome (DOID:13087)
10Kleefstra 综合征 (DOID:0060352) Kleefstra syndrome (DOID:0060352)
23致死性先天性挛缩综合征(DOID:0060558) lethal congenital contracture syndrome (DOID:0060558)
10正中弓状韧带综合征(DOID:9892) median arcuate ligament syndrome (DOID:9892)
26产品列表
-
13-(cyclopropylamino)-5-(4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one化合物 CID: 57559562Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C608632查看产品价格与包装
技术标识符
- IUPAC名称
- 13-(cyclopropylamino)-5-(4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one
- SMILES
- COc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ncn1)NC1CC1
- InChIKey
- DBUMITZHDMTTNX-UHFFFAOYSA-N
- InChI
- 1S/C18H15N5O2S/c1-25-12-6-4-11(5-7-12)23-9-21-14-13-16(22-10-2-3-10)19-8-20-17(13)26-15(14)18(23)24/h4-10H,2-3H2,1H3,(H,19,20,22)
-
13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF₁α化合物 CID: 5311240Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D607062查看产品价格与包装
技术标识符
- IUPAC名称
- 7-[(1R,2R,3R,5S)-2-[(3R)-4-(3-chlorophenoxy)-3-hydroxybutyl]-3,5-dihydroxycyclopentyl]heptanoic acid
- SMILES
- O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O
- InChIKey
- XECZBZWECQIBDA-LELZANKISA-N
- InChI
- 1S/C22H33ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h5-7,12,16,18-21,24-26H,1-4,8-11,13-14H2,(H,27,28)/t16-,18-,19-,20+,21-/m1/s1
-
1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]ureaMoligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: T609257查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea
- SMILES
- O=C(Nc1cc(C(C)(C)C)nn1c1cn(CCN(C)C)nc1)N[C@H]1CC[C@@H](Oc2ccc3n(c2)c(nn3)N2[C@@H](C)CCCC2)c2c1cccc2
- InChIKey
- PPZSTJQLZOPKBO-LGXAAPQCSA-N
- InChI
- 显示更多
-
1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea化合物 CID: 71458575Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C608659查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea
- SMILES
- CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
- InChIKey
- RZFJBSIAXYEPBX-UHFFFAOYSA-N
- InChI
- 1S/C27H28ClN7O3S/c1-4-35(5-2)39(37,38)25-17-21(10-11-22(25)28)32-26-31-15-13-23(34-26)19-12-14-30-24(16-19)18-6-8-20(9-7-18)33-27(36)29-3/h6-17H,4-5H2,1-3H3,(H2,29,33,36)(H,31,32,34)
-
1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine化合物 CID: 46871653Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C609341查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine
- SMILES
- Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccnc(c1)N1CCNCC1)C(F)(F)F
- InChIKey
- AHZCYZMNFBGXAC-UHFFFAOYSA-N
- InChI
- 1S/C24H24ClF3N6/c25-19-1-2-20(24(26,27)28)18(11-19)15-34-10-7-31-23-21(34)12-17(14-32-23)16-3-4-30-22(13-16)33-8-5-29-6-9-33/h1-4,11-14,29H,5-10,15H2,(H,31,32)
-
11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one化合物 CID: 46866191Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608980查看产品价格与包装
技术标识符
- IUPAC名称
- 11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one
- SMILES
- Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)N
- InChIKey
- NGINYBBVZOLUBV-UHFFFAOYSA-N
- InChI
- 1S/C15H12N6OS/c1-7-2-4-8(5-3-7)21-6-18-10-9-12(16)19-15(17)20-13(9)23-11(10)14(21)22/h2-6H,1H3,(H4,16,17,19,20)
-
1-[4-[methyl-[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea化合物 CID: 5329829Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M611956查看产品价格与包装
技术标识符
- SMILES
- O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
- InChIKey
- SNRUTMWCDZHKKM-UHFFFAOYSA-N
- InChI
- 1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)
-
1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea化合物 CID: 73659199Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M608958查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea
- SMILES
- CCCn1cnc(c1)CCNC(=O)Nc1nc2c(s1)cc(cc2)c1cncc(c1)OC
- InChIKey
- VYPWROGLWNYKDD-UHFFFAOYSA-N
- InChI
- 1S/C22H24N6O2S/c1-3-8-28-13-17(25-14-28)6-7-24-21(29)27-22-26-19-5-4-15(10-20(19)31-22)16-9-18(30-2)12-23-11-16/h4-5,9-14H,3,6-8H2,1-2H3,(H2,24,26,27,29)
-
2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide化合物 CID: 145996540Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608737查看产品价格与包装
技术标识符
- IUPAC名称
- 2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide
- SMILES
- COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2n(c1)c(cn2)c1nnc(o1)CCN1CCN(CC1)C
- InChIKey
- LSPJWTULWKYRTQ-UHFFFAOYSA-N
- InChI
- 1S/C28H28F2N8O4S/c1-36-9-11-37(12-10-36)8-7-26-33-34-28(42-26)23-16-31-25-6-3-18(17-38(23)25)19-13-22(27(41-2)32-15-19)35-43(39,40)24-5-4-20(29)14-21(24)30/h3-6,13-17,35H,7-12H2,1-2H3
-
2,2,2-TEMPSCAS: 353234-67-0 化合物 CID: 11362035Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: T607095查看产品价格与包装
技术标识符
- IUPAC名称
- 2,2,2-trifluoro-N-(3-pentan-2-yloxyphenyl)-N-(pyridin-3-ylmethyl)ethanesulfonamide
- SMILES
- CCCC(Oc1cccc(c1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1)C
- InChIKey
- ICFXZBZASBXILF-UHFFFAOYSA-N
- InChI
- 1S/C19H23F3N2O3S/c1-3-6-15(2)27-18-9-4-8-17(11-18)24(13-16-7-5-10-23-12-16)28(25,26)14-19(20,21)22/h4-5,7-12,15H,3,6,13-14H2,1-2H3
-
2,6-dichloro-4-[2-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c]quinolin-8-yl]phenol化合物 CID: 165368933Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609463查看产品价格与包装
技术标识符
- SMILES
- Oc1c(Cl)cc(c2ccc3ncc4nc(C)n(C5CCN(C)CC5)c4c3c2)cc1Cl
- InChIKey
- JEESDVDVWGRNFE-UHFFFAOYSA-N
- InChI
- 1S/C23H22Cl2N4O/c1-13-27-21-12-26-20-4-3-14(15-10-18(24)23(30)19(25)11-15)9-17(20)22(21)29(13)16-5-7-28(2)8-6-16/h3-4,9-12,16,30H,5-8H2,1-2H3
-
2'-Me-CCPA化合物 CID: 10475082Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M607125查看产品价格与包装
技术标识符
- IUPAC名称
- (2R,3R,4R,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)-3-methyloxolane-3,4-diol
- SMILES
- OC[C@H]1O[C@H]([C@]([C@@H]1O)(C)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
- InChIKey
- MMPAUXMIDJWGFO-ROMFRFKVSA-N
- InChI
- 1S/C16H22ClN5O4/c1-16(25)11(24)9(6-23)26-14(16)22-7-18-10-12(19-8-4-2-3-5-8)20-15(17)21-13(10)22/h7-9,11,14,23-25H,2-6H2,1H3,(H,19,20,21)/t9-,11-,14-,16-/m1/s1
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
应如何使用细胞增殖性疾病分类?
可用细胞增殖性疾病快速组建候选化合物集,再逐一对照各化合物的靶点页面及其活性检测方法进行核实。疾病注释反映的是已报道的关联性,而非已验证的适应症。
细胞增殖性疾病与目录其他部分是什么关系?
细胞增殖性疾病归属于按疾病分类(DOID),是按疾病注释组织的视图,其中化合物同时也收录在各自的分子靶点下。可用它快速圈定范围,再在靶点页面逐一确认。
从细胞增殖性疾病订购化合物前应核查什么?
对于细胞增殖性疾病中的任何化合物,请核查所报道活性的检测方法、种属相关性、纯度,以及推荐的母液溶剂和储存条件。批次专属数据见分析证书。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
可以为细胞增殖性疾病定制化合物集吗?
细胞增殖性疾病下的化合物可按靶点、作用机制和化合物类别筛选,并可按您指定的板型提供按需挑选的化合物集。需求请提交至 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![13-(cyclopropylamino)-5-(4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C608632.png)

![1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/T/6/T609257.png)
![1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C608659.png)
![1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C609341.png)
![11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608980.png)
![1-[4-[methyl-[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M611956.png)
![1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M608958.png)
![2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608737.png)

![2,6-dichloro-4-[2-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c]quinolin-8-yl]phenol](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609463.png)

危险品化学品经营许可证(带存储)